Most investigations of T-cell-mediated cytotoxicity and tumor control have focused on MHC-I restricted, CD8' Tcell-mediated cytotoxicity,'",'' but several observations suggest that CD4+ T cells are critical regulators of the normal humoral immune response as well as of aberrant B-cell proliferation~.''-'~ Small, noncleaved cell lymphoma (SNCL; Burkitt's) is a pathologically distinct subset of B-cell lymphomas that represents the malignant outgrowth of germinal center B ~ells.'~,'' We have shown that activated CD4+ T cells can modulate the growth of Ramos Burkitt's lymphoma (BL) B-cell line cells by ligating CD40 at the Bcell surface, which results in Fas upregulation and confers sensitivity to Fas-mediated death signals.I8 The finding that CD40 ligation could result in augmented Fas expression and fun~tion'~.''.'' was somewhat surprising in the context of CD40's previously known function in transducing a potent B-cell activation, differentiation, and survival ~ignal.'"~'~ In our laboratory, this observation was largely an outcome of work in which the Ramos cells were used as a model for studying germinal center B-cell activation and function.
To see if CD4' T-cell mediated Fas upregulation and Bcell death reflects a peculiarity of the Ramos B-cell line cells or is applicable to other BL, we tested this signaling pathway using other Burkitt's cell lines. In addition, we implemented our system using malignant BL cells isolated from the peripheral blood of a patient with chemotherapy-resistant dis- Flow cyfot?wtric cell cycle ctttftlysis. After Ficoll-Hypaque centrifugation. purified. viable cells were permeabilized in 7 0 9 ethanol at 0°C for 15 minutes. washed IX in HBSS. and resuspended in HRSS containing propidium iodide at 50 pgImL with RNAse at 5 pglmL. After incubation at 37°C for 30 minutes. the suspensions were stored in the dark at 4°C until the time of analysis. DNAs were analyzed directly on the Becton Dickinson FACScan.
AlcmorBltrc cell prolj$vwfiort ct.s.scry. The alamarBlue RuorometricIcolorimetric growth indicator (Biosource Int) was used to measure cell proliferation and susceptibility to Fas-mediated killing."' Target B-cell line cells that had been exposed in macrowells to media only. to either CD40L-or CD40L' T cells. or to either monoclonal anti-CD40 or an isotype-matched control MoAh were replated in sterile 96-well round-bottom plates at a uniform concentration and volume. The cells were then exposed to media only, anti-Fas antibody (final concentration. 200 ngImL), or anti-CD23 antibody (200 ngImL). After an additional 36 hours, alamarBlue was added (10% by volume) to each well and the relative number of proliferating cells was determined 6 hours later by spectroscopy (excitation. 530 nm: emission. 590 nm) using a CytoFluor 2350 fluorescent plate reader (Millipore Corp. Bedford. MA). For each circumstance, the experiments were performed in triplicate and the relative number of proliferating cells was determined as the mean fluorescence scanning result for each culture circumstance, less the mean obtained for three wells with media alone (background). The results shown represent the mean result obtained from three separate experiments. Standard errors were determined using SigmaPlot (Jandel Scientific, San Rafael. CA). in vitro to mimic the effects of Fas ligand on Fas-expressing cells." As shown in Fig 3. after CD40 ligation by the T cells, there is an acquired, specific susceptibility to Fasmediated death signals. For these experiments, after 48 hours of coculture, the target B cells were aliquoted in microwell cytotoxicity plates and exposed either to media alone or to anti-Fas or an isotype-matched control antibody (anti-CD23) at 200 ng/mL. AIamarBlue analysis of the proliferating cell populations after an additional 36 hours showed that specific inhibition of proliferation in response to anti-Fas MoAb occurred only after the cells had been exposed to CD40L' T cells in coculture. The results indicate that, in all of the EBVnegative BL B-cell lines examined except for ST486, the cells express low levels of Fas and are resistant to Fasmediated cytotoxicity. In each of these lines except for CA46, the BL cells respond to CD40-mediated signals by upregulating Fas and becoming sensitive to Fas-mediated cytotoxicity. Although there is heterogeneity in the degree of conferred sensitivity among the BL cell lines, it is clear that the capacity to undergo Fas-mediated apoptosis is enhanced in at least 4 of the cases.
RESULTS

RL B-cell line cells that constitlrtivel~ e.rpress IOW levels
Tumor cells from a resistant Burkitt 'S lymphoma/leukemin case undergo Fas-mediated apoptosis after coculture with CD40L' Jurkat T-cell mutants. Malignant B cells were isolated from the peripheral blood of a human immunodeficiency virus (H1V)-negative patient with refractory Burkitt's lymphoma that progressed to a leukemic phase. The patient was a 34-year-old man who presented with odynophagia and a rapidly growing mass at the base of his tongue. Biopsy of the mass, which involved Waldeyer's ring, showed a monotonous population of cells, with numerous mitotic figures and macrophages, consistent with a small, non-cleaved cell (SNCC; Burkitt's) lymphoma (Fig 4A) . Despite intensive combination chemotherapy, his disease progressed, and within 4 months, the peripheral blood smear showed circulating Burkitt's lymphoma cells (French-American-British classification L3 leukemia; Fig 4C) , and the bone marrow was replaced by malignant lymphoid cells (Fig 4B) . The patient died approximately 6 months after the onset of his clinical illness.
The patient's cells were cultured in the presence of media or with CD40L-or CD40L' irradiated T-cell clones and then analyzed by immunofluorescence flow cytometry for Fas expression (Fig 5) . There was constitutively low Fas expression on the B cells cultured with media alone and with CD40L-T cells. In contrast, after coculture with CD40L' Jurkat T cells, a significant proportion of this patient's BL cells expressed augmented levels of the Fas antigen (double positives, right lower panel) and underwent apoptosis (Fig  6 4 . For this analysis, after 48 hours of coculture, viable cells were isolated by Ficoll-Hypaque centrifugation and then analyzed for DNA fragmentation. Flow cytometric cell cycle analysis after propidium iodide staining showed dramatic augmentation of the subdiploid (apoptotic) DNA only after coculture with the CD40L' Jurkat T cells. To clarify the mechanism of cell death, in another set of experiments, the patient's cells were exposed in coculture to the CD40L' T cells in the presence of a blocking F(ab'), preparation of anti-Fas (Fig 6b) . As shown, there is a partial but dosedependent inhibition of apoptosis in the presence of the blocking antibody to Fas, whereas there is no effect seen with the control antibody preparation. Taken together, these experiments indicate that the patient's BL cells can be manipulated by ligation of CD40 such that they are rendered susceptible to Fas-mediated cytolysis.
DISCUSSION
Epidemiologic data indicate that patients who carry CD4' T-cell deficiencies have a propensity to develop B-cell nonHodgkin's lymphoma (NHL),'x but the precise molecular mechanisms of failed immune surveillance of aberrant Bcell proliferations in that setting have not been established. The data presented in this work provide a link between Fas ligand-expressing cytotoxic CD4' T cells and Fas-mediated apoptosis of BL cells. We have shown that EBV-negative BL B cells specifically upregulate Fas and become sensitive to Fas-mediated signals after ligation of CD40 at the B-cell surface. This result was obtained in 4 of the 5 BL cell lines that are constitutively resistant to Fas-mediated cytolysis and in malignant cells isolated from a patient with chemotherapyresistant disease. These results support an immunoregulatory role for CD4' T cells via the Fas-Fas ligand system and have important implications for both the pathogenesis and therapy of Burkitt's lymphoma.
Once Fas is upregulated in the BL cells, the sensitivity to Fas-mediated cytolysis is variable. It is possible that some resistant tumors carry defects in the Fas receptor itself, such a s have been described in one murine B-cell lymphoma'" or that some bear defects in the distal Fas signaling pathway.' Although it is not a factor in the cell lines reported here, EBV may be important in conferring resistance to Fas-mediated cytolysis in EBV-positive BL. Although the role of specific EBV proteins in conferring specific resistance to Fas-mediated apoptosis is unknown, LMP-I has been shown to bind to a molecule associated with the cytoplasmic domain of CD40 (CRAF-I) and, to a lesser extent, with TNF receptor and Fas-associated cytosolic molecules. cross-linking of the surface antigen receptor. This mechanism could explain some cases of sporadic Burkitt's lymphoma that, based on Ig sequence analysis, are reported to be antigen-driven.'* Although Burkitt's lymphoma is not usually ascribed to T-cell defects, the high incidence of this malignancy in pa-SCHATTNER ET AL in (a) , but in the presence or absence of a blocking anti-Fas F(ab'I2 or a control antibody preparation. Apoptosis was assessed by PI staining followed by flow cytometry and cell cycle analysis. The inhibition in the presence of each antibody preparation is shown relative to that observed with the CD40L-T cells alone, without any antibody added. < tients with HIV disease.'.'..'' suggests that our findings (which implicate CD4' T cells) have physiologic relevance. Our observations are consistent with the clinical picture of polyclonal B-cell proliferations in HIV,." a high incidence of autoantibody production,." and the emergence of uncontrolled clonal expansions. Without HIV, CD4' aberrations leading to failed Fas upregulation and impaired B-cell apoptosis may be quite subtle and go unrecognized by routine clinical and laboratory parameters. These abnormalities might include inherited, iatrogenic, and infection-associated changes in the CD4' T-cell population, such as those that occur due to malaria.. " We would emphasize that, in the experiments reported here, the ratio of effector T to target malignant B cells in coculture was 1:4. This suggests that. in sensitive tumor cell populations, a relatively small proportion of cytotoxic T cells can cause death of a substantial B-cell tumor cell population. The fact that BL B cells that constitutively express low or even undetectable Fas levels can be killed by Fas-mediated signals after appropriate T-cell stimulation indicates that the Fas-Fas ligand system may be critical in immune modulation of tumors that are not known to express the Fas antigen. Our data, which show undetectable or low constitutive Fas expression on each BL line examined, are consistent with previous studies that describe BL as a Fas-negative tumor.." The capacity to manipulate Fas expression may be applicable to other B-cell tumors such as chronic lymphocytic leukemia or follicular non-Hodgkin's lymphomas, which display resting or inactivated B-cell phenotypes, but which might upregulate Fas in response to appropriate signals and then become sensitive to apoptosis. 
